During the past decade, Evanston Premier Healthcare Research LLC conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 14 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Evanston Premier Healthcare Research LLC" #1 sponsor was "Pfizer" with 5 trials, followed by "NewAmsterdam Pharma" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored and "Pronova BioPharma" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Evanston Premier Healthcare Research LLC" #1 collaborator was "CoLucid Pharmaceuticals" with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Evanston Premier Healthcare Research LLC" are "Dyslipidemias" (3 trials), "High Cholesterol" (3 trials), "Hypercholesterolemia" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Evanston Premier Healthcare Research LLC" in a lesser frequency.

Most popular intervention types in "Evanston Premier Healthcare Research LLC" are "Drug" (21 trials), "Other" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Obicetrapib" (2 trials), "PRC-4016" (2 trials), "Tolterodine Tartrate ER" (2 trials) and "V114" (2 trials). Other intervention names were less common.

The vast majority of trials in "Evanston Premier Healthcare Research LLC" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Evanston Premier Healthcare Research LLC". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Evanston Premier Healthcare Research LLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Evanston Premier Healthcare Research LLC, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".